NPS's Nader on Drug Research, Growth Strategy

NPS's Nader on Drug Research, Growth Strategy Play

Feb. 25 (Bloomberg) -- Francois Nader, chief excutive officer for NPS Pharmaceuticals Inc., talks about cost strategy and product development. Nader speaks with Sara Eisen and Tom Keene on Bloomberg Television's "Surveillance." Stanley Collender, managing director for Qorvis Communications LLC, also speaks. (Source: Bloomberg)

  • On Air Now

    The Pulse Watch Now

  • Next

    Bloomberg Surveillance

blog comments powered by Disqus